MRK

Merck & Co., Inc.

HealthcareDrug Manufacturers - GeneralUSUSD

$118.72

+2.11%Live · FMPMay 29, 2026

Market cap

$293.22B

52w range

75.40 – 125.14

P / E

—

EPS

—

Volume

6.34M

Revenue · FY

$64.93B

+1.18% YoY

Stock splits

DB · stock_splits7

Date	Ratio	Type	Multiplier
Jun 03, 2021	131-for-125	Forward	1.05×
Feb 17, 1999	2-for-1	Forward	2.00×
May 26, 1992	3-for-1	Forward	3.00×
May 26, 1988	3-for-1	Forward	3.00×
May 27, 1986	2-for-1	Forward	2.00×
Jun 01, 1972	2-for-1	Forward	2.00×
May 27, 1964	3-for-1	Forward	3.00×

1DB · FMP /mergers-acquisitions

Whole-company transactions where MRK is acquirer or target.

Date	Role	Counterparty	Filing
Dec 18, 1995	Acquirer	Schering	SEC →

DB · 13D/G6

Filed	Form	Reporter	% owned	Shares
Jan 23, 2024	—	Merck Global Health Innovation Fund, LLC	11.40%	—	SEC →
Jan 23, 2024	—	Merck Sharp & Dohme LLC	11.40%	—	SEC →
Jan 23, 2024	—	Merck & Co., Inc.	11.40%	—	SEC →
Feb 02, 2022	—	Merck Sharp & Dohme Corp.	6.60%	—	SEC →
Feb 02, 2022	—	Merck & Co., Inc.	6.60%	—	SEC →
Feb 01, 2022	—	(1) BlackRock, Inc.	7.80%	—	SEC →

Corporate actions combine splits (live, full history), symbol changes (refreshed weekly), the daily M&A wire, and 13D/G filings.